Auris Health

Johnson & Johnson (NYSE: JNJ) stands accused in a lawsuit of deceiving investors regarding performance-based earnings from Auris Health Inc, a medical-robot company it acquired last year for $5.7 billion, Bloomberg reported Monday. What Happened: The lawsuit, filed in the Delaware Court of...

Auris Medical Holding AG (NASDAQ: EARS) stock traded higher by as much as 30 percent Wednesday morning after Johnson & Johnson (NYSE: JNJ) announced a $3.4 billion buyout of Auris Health. The only problem? Auris Medical Holding has nothing to do with Auris Health or the buyout. How It Happens...